| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ling Lin, Jing Ye, Han Zhang, Zhong-Fu Han, Zhi-Hong Zhen. Degree of dopaminergic degeneration measured by Neural regeneration research. vol 13. issue 7. 2020-10-01. PMID:30028339. |
dopamine transporters (dat) in the striatum regulate synaptic dopamine levels, and striatal |
2020-10-01 |
2023-08-13 |
Not clear |
| Srivadee Oravivattanakul, Lucas Benchaya, Guiyun Wu, Anwar Ahmed, Ilia Itin, Scott Cooper, Michal Gostkowski, Joseph Rudolph, Kristin Appleby, Patrick Sweeney, Hubert H Fernande. Dopamine Transporter (DaT) Scan Utilization in a Movement Disorder Center. Movement disorders clinical practice. vol 3. issue 1. 2020-10-01. PMID:30363515. |
dopamine transporter (dat) scan utilization in a movement disorder center. |
2020-10-01 |
2023-08-13 |
Not clear |
| Srivadee Oravivattanakul, Lucas Benchaya, Guiyun Wu, Anwar Ahmed, Ilia Itin, Scott Cooper, Michal Gostkowski, Joseph Rudolph, Kristin Appleby, Patrick Sweeney, Hubert H Fernande. Dopamine Transporter (DaT) Scan Utilization in a Movement Disorder Center. Movement disorders clinical practice. vol 3. issue 1. 2020-10-01. PMID:30363515. |
the aim of this work was to describe utilization patterns of dopamine transporter (dat) scan and its influence on patient management at a single movement disorders center. |
2020-10-01 |
2023-08-13 |
Not clear |
| Susanna Jakobson Mo, Jan Linder, Lars Forsgren, Katrine Riklun. Accuracy of Visual Assessment of Dopamine Transporter Imaging in Early Parkinsonism. Movement disorders clinical practice. vol 2. issue 1. 2020-10-01. PMID:30363855. |
dopamine transporter (dat) imaging may be supportive in the initial clinical diagnostic workup in patients with suspected parkinsonian diseases, given that the method has the potential to detect dopaminergic degeneration. |
2020-10-01 |
2023-08-13 |
Not clear |
| Raquel Romay-Tallon, Erin Kulhawy, Kyle J Brymer, Josh Allen, Tania Rivera-Baltanas, Jose M Olivares, Lisa E Kalynchuk, Hector J Carunch. Changes in Membrane Protein Clustering in Peripheral Lymphocytes in an Animal Model of Depression Parallel Those Observed in Naïve Depression Patients: Implications for the Development of Novel Biomarkers of Depression. Frontiers in pharmacology. vol 9. 2020-10-01. PMID:30374301. |
afterward they underwent the forced swim test to evaluate depression-like behavior, and isolated lymphocytes were analyzed by immunocytochemistry coupled to image-analysis to study clustering parameters of the sert, 5ht2a receptor, dopamine transporter (dat), beta2 adrenergic receptor (β2ar), nmda 2b receptor (nr2b), pannexin 1 (pnx1), and prion cellular protein (prpc). |
2020-10-01 |
2023-08-13 |
human |
| Susanna Jakobson Mo, Jan Axelsson, Lars Jonasson, Anne Larsson, Mattias J Ögren, Margareta Ögren, Andrea Varrone, Linda Eriksson, David Bäckström, Sara Af Bjerkén, Jan Linder, Katrine Riklun. Dopamine transporter imaging with [ EJNMMI research. vol 8. issue 1. 2020-10-01. PMID:30443684. |
dopamine transporter imaging with [ dopamine transporter (dat) imaging may be of diagnostic value in patients with clinically suspected parkinsonian disease. |
2020-10-01 |
2023-08-13 |
Not clear |
| Seunghyeon Shin, Keunyoung Kim, Jae Meen Lee, Eun Joo Kim, Seong Jang Kim, In Joo Kim, Kyoungjune Pak, Myung Jun Le. Effect of Single-Nucleotide Polymorphisms on Decline of Dopamine Transporter Availability in Parkinson's Disease. Journal of clinical neurology (Seoul, Korea). vol 15. issue 1. 2020-10-01. PMID:30618224. |
we aimed to determine the association between the annual changes in dopamine transporter (dat) availability as measured by ¹²³i-ioflupane (¹²³i-fp-cit) single-photon-emission computed tomography and single-nucleotide polymorphisms (snps) known to be risk factors in parkinson's disease (pd). |
2020-10-01 |
2023-08-13 |
Not clear |
| Yu Iwabuchi, Tadaki Nakahara, Masashi Kameyama, Yoshitake Yamada, Masahiro Hashimoto, Yohji Matsusaka, Takashi Osada, Daisuke Ito, Hajime Tabuchi, Masahiro Jinzak. Impact of a combination of quantitative indices representing uptake intensity, shape, and asymmetry in DAT SPECT using machine learning: comparison of different volume of interest settings. EJNMMI research. vol 9. issue 1. 2020-10-01. PMID:30689072. |
we sought to assess the machine learning-based combined diagnostic accuracy of three types of quantitative indices obtained using dopamine transporter single-photon emission computed tomography (dat spect)-specific binding ratio (sbr), putamen-to-caudate ratio (pcr)/fractal dimension (fd), and asymmetry index (ai)-for parkinsonian syndrome (ps). |
2020-10-01 |
2023-08-13 |
Not clear |
| Donglang Jiang, Xiuhong Lu, Zijing Li, Nicklas Rydberg, Chuantao Zuo, Fangyu Peng, Fengchun Hua, Yihui Guan, Fang Xi. Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent. Frontiers in neuroscience. vol 12. 2020-10-01. PMID:30697146. |
increased vesicular monoamine transporter 2 (vmat2) and dopamine transporter (dat) expression in adolescent brain development: a longitudinal micro-pet/ct study in rodent. |
2020-10-01 |
2023-08-13 |
Not clear |
| L M Chahine, A Iranzo, A Fernández-Arcos, T Simuni, N Seedorff, C Caspell-Garcia, A W Amara, C Comella, B Högl, J Hamilton, K Marek, G Mayer, B Mollenhauer, R Postuma, E Tolosa, C Trenkwalder, A Videnovic, W Oerte. Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder. NPJ Parkinson's disease. vol 5. 2020-10-01. PMID:30701189. |
dopamine transporter (dat) binding deficit predicts conversion to α-synuclein-related disorders in individuals with rbd. |
2020-10-01 |
2023-08-13 |
human |
| Srivadee Oravivattanakul, Lucas Benchaya, Anwar Ahmed, Ilia Itin, Scott Cooper, Michal Gostkowski, Joseph Rudolph, Kristin Appleby, Patrick Sweeney, Hubert H Fernandez, Guiyun W. Reply to Comment on: Dopamine Transporter (DaT) Scan Utilization in a Movement Disorder Center. Movement disorders clinical practice. vol 4. issue 1. 2020-10-01. PMID:30713966. |
reply to comment on: dopamine transporter (dat) scan utilization in a movement disorder center. |
2020-10-01 |
2023-08-13 |
Not clear |
| Shakya Bhattacharjee, Vijaya Shankar, Mohammed Elkide. Comment on: Dopamine Transporter (DaT) Scan Utilization in a Movement Disorder Center. Movement disorders clinical practice. vol 4. issue 1. 2020-10-01. PMID:30713965. |
comment on: dopamine transporter (dat) scan utilization in a movement disorder center. |
2020-10-01 |
2023-08-13 |
Not clear |
| Xuan He, Shuangshuang Yang, Rui Zhang, Lina Hou, Jianrong Xu, Yaer Hu, Rang Xu, Hao Wang, Yongfang Zhan. Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid-Lesioned Parkinson's Disease Models. Frontiers in cellular neuroscience. vol 13. 2020-10-01. PMID:30804756. |
smi increased the tyrosine hydroxylase (th) positive and nissl positive neuron number in the substantia nigra pars compacta (snpc), augmented striatal da and its metabolites concentration and elevated striatal dopamine transporter density (dat). |
2020-10-01 |
2023-08-13 |
mouse |
| Etienne Cartier, Jennie Garcia-Olivares, Eric Janezic, Juan Viana, Michael Moore, Min Landon Lin, Jeffrey L Caplan, Gonzalo Torres, Yong-Hwan Ki. The SUMO-Conjugase Ubc9 Prevents the Degradation of the Dopamine Transporter, Enhancing Its Cell Surface Level and Dopamine Uptake. Frontiers in cellular neuroscience. vol 13. 2020-10-01. PMID:30828290. |
the dopamine transporter (dat) is a plasma membrane protein responsible for the uptake of released dopamine back to the presynaptic terminal and ending dopamine neurotransmission. |
2020-10-01 |
2023-08-13 |
Not clear |
| Etienne Cartier, Jennie Garcia-Olivares, Eric Janezic, Juan Viana, Michael Moore, Min Landon Lin, Jeffrey L Caplan, Gonzalo Torres, Yong-Hwan Ki. The SUMO-Conjugase Ubc9 Prevents the Degradation of the Dopamine Transporter, Enhancing Its Cell Surface Level and Dopamine Uptake. Frontiers in cellular neuroscience. vol 13. 2020-10-01. PMID:30828290. |
the dat is the molecular target for cocaine and amphetamine as well as a number of pathological conditions including autism spectrum disorders, attention-deficit hyperactivity disorder (adhd), dopamine transporter deficiency syndrome (dtds), and parkinson's disease. |
2020-10-01 |
2023-08-13 |
Not clear |
| Arda Könik, Jan De Beenhouwer, Joyeeta M Mukherjee, Kesava Kalluri, Soumyanil Banerjee, Navid Zeraatkar, Timothy Fromme, Michael A Kin. Simulations of a Multi-Pinhole SPECT Collimator for Clinical Dopamine Transporter (DAT) Imaging. IEEE transactions on radiation and plasma medical sciences. vol 2. issue 5. 2020-10-01. PMID:31011693. |
simulations of a multi-pinhole spect collimator for clinical dopamine transporter (dat) imaging. |
2020-10-01 |
2023-08-13 |
Not clear |
| Arda Könik, Jan De Beenhouwer, Joyeeta M Mukherjee, Kesava Kalluri, Soumyanil Banerjee, Navid Zeraatkar, Timothy Fromme, Michael A Kin. Simulations of a Multi-Pinhole SPECT Collimator for Clinical Dopamine Transporter (DAT) Imaging. IEEE transactions on radiation and plasma medical sciences. vol 2. issue 5. 2020-10-01. PMID:31011693. |
spect imaging of the dopamine transporter (dat) is used for diagnosis and monitoring progression of parkinson's disease (pd), and differentiation of pd from other neurological disorders. |
2020-10-01 |
2023-08-13 |
Not clear |
| Xun Sun, Fang Liu, Qingyao Liu, Yongkang Gai, Weiwei Ruan, Dilani Neranjana Wimalarathne, Fan Hu, Xubo Tan, Xiaoli La. Quantitative Research of Frontiers in neuroscience. vol 13. 2020-10-01. PMID:31024233. |
quantitative research of dopamine transporter (dat) and glucose metabolism imaging have been applied in the diagnosis of parkinson's disease (pd). |
2020-10-01 |
2023-08-13 |
Not clear |
| Mario Díaz, Ana Canerina Luis-Amaro, Deiene Rodriguez Barreto, Verónica Casañas-Sánchez, José A Pérez, Raquel Mari. Lipostatic Mechanisms Preserving Cerebellar Lipids in MPTP-Treated Mice: Focus on Membrane Microdomains and Lipid-Related Gene Expression. Frontiers in molecular neuroscience. vol 12. 2020-10-01. PMID:31105522. |
pcr and immunohistochemical analyses of both brain areas revealed that dopamine transporter (dat) mrna and protein were expressed in oc but not in the cerebellum. |
2020-10-01 |
2023-08-13 |
mouse |
| Sylvie Chalon, Johnny Vercouillie, Pierre Payoux, Jean-Bernard Deloye, Cécile Malherbe, Florence Le Jeune, Nicolas Arlicot, Anne-Sophie Salabert, Denis Guilloteau, Patrick Emond, Maria-Joao Ribeir. The Story of the Dopamine Transporter PET Tracer LBT-999: From Conception to Clinical Use. Frontiers in medicine. vol 6. 2020-10-01. PMID:31131278. |
the membrane dopamine transporter (dat) is involved in a number of brain disorders and its exploration by positron emission tomography (pet) imaging is highly relevant for the early and differential diagnosis, follow-up and treatment assessment of these diseases. |
2020-10-01 |
2023-08-13 |
Not clear |